Related references
Note: Only part of the references are listed.Detection of hypermethylation BRCA1/2 gene promoter in breast tumours among Moroccan women
Imane Saif et al.
MOLECULAR BIOLOGY REPORTS (2021)
Loss of BRCA1 expression and morphological features associated with BRCA1 promoter methylation status in triple-negative breast cancer
Arisa Morizono et al.
JOURNAL OF HUMAN GENETICS (2021)
The Clinical and Pathological Profile of BRCA1 Gene Methylated Breast Cancer Women: A Meta-Analysis
Ilary Ruscito et al.
CANCERS (2021)
BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer
Karolina Prajzendanc et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Curcumin induces re-expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines
Nujoud Al-Yousef et al.
ONCOLOGY REPORTS (2020)
Genetic and epigenetic profiling of BRCA1/2 in ovarian tumors reveals additive diagnostic yield and evidence of a genomic BRCA1/2 DNA methylation signature
Erfan Aref-Eshghi et al.
JOURNAL OF HUMAN GENETICS (2020)
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
Dominik Glodzik et al.
NATURE COMMUNICATIONS (2020)
BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy
Olafur A. Stefansson et al.
JNCI CANCER SPECTRUM (2020)
Genetic testing in Poland and Ukraine: should comprehensive germline testing ofBRCA1andBRCA2be recommended for women with breast and ovarian cancer?
Tu Nguyen-Dumont et al.
GENETICS RESEARCH (2020)
DNMT Inhibitors Increase Methylation in the Cancer Genome
Anil K. Giri et al.
FRONTIERS IN PHARMACOLOGY (2019)
Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors
Parisa Paydar et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
Johan Staaf et al.
NATURE MEDICINE (2019)
Genomic Profile and BRCA-1 Promoter Methylation Status in BRCA Mutated Ovarian Cancer: New Insights in Predictive Biomarkers of Olaparib Response
Elisena Franzese et al.
FRONTIERS IN ONCOLOGY (2019)
Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies
Clara Bodelon et al.
BREAST CANCER RESEARCH (2019)
DNA methylation in epigenetic inheritance of metabolic diseases through the male germ line
Louise Ruby Hoj Illum et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk
Per E. Lonning et al.
ANNALS OF INTERNAL MEDICINE (2018)
A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?
Shoko Vos et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Timothy R. Rebbeck et al.
HUMAN MUTATION (2018)
gDNA extraction yield and methylation status of blood samples are affected by long-term storage conditions
Charlotte Schroeder et al.
PLOS ONE (2018)
A Dominantly Inherited 5' UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer
D. Gareth R. Evans et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer
Paula Silva Felicio et al.
ONCOTARGET (2017)
Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine
I. Gorodetska et al.
FAMILIAL CANCER (2017)
The Roles of DNA Methylation in the Stages of Cancer
K. Wyatt McMahon et al.
CANCER JOURNAL (2017)
BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
Shoko Vos et al.
BREAST CANCER RESEARCH (2017)
Methylation Analysis of BRCA1 and APC in Breast Cancer and It's Relationship to Clinicopathological Features
Halaleh Shakeri et al.
CLINICAL LABORATORY (2016)
The Potential Contribution of BRCA Mutations to Early Onset and Familial Breast Cancer in Uzbekistan
Abdulla Abdikhakimov et al.
CENTRAL ASIAN JOURNAL OF GLOBAL HEALTH (2016)
Quantitative detection of methylation of FHIT and BRCA1 promoters in the serum of ductal breast cancer patients
Limei Liu et al.
BIO-MEDICAL MATERIALS AND ENGINEERING (2015)
Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer
X. Zhu et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer
Nami Yamashita et al.
CLINICAL BREAST CANCER (2015)
Promoter methylation and expression changes of BRCA1 in cancerous tissues of patients with sporadic breast cancer
Qiuyun Li et al.
ONCOLOGY LETTERS (2015)
Promoter Hypermethylation in White Blood Cell DNA and Breast Cancer Risk
Yoon Hee Cho et al.
JOURNAL OF CANCER (2015)
The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine
Ielizaveta Gorodetska et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2015)
Clinicopathological Significance of BRCA1 Promoter Hypermethylation in Thai Breast Cancer Patients
Pensri Saelee et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
BRCA1 Promoter Hypermethylation Signature for Early Detection of Breast Cancer in the Vietnamese Population
Phuong Kim Truong et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females
Nisreen Al-Moghrabi et al.
BMC CANCER (2014)
Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer
Satish Gupta et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer
Yoko Otani et al.
CANCER SCIENCE (2014)
Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy
Y. Xu et al.
ANNALS OF ONCOLOGY (2013)
Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer
Tarique N. Hasan et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
Methylation of BRCA1 Promoter Region Is Associated with Unfavorable Prognosis in Women with Early-Stage Breast Cancer
Nicholas C. Hsu et al.
PLOS ONE (2013)
Comparison of Methylation Profiling in Cancerous and Their Corresponding Normal Tissues from Korean Patients with Breast Cancer
Eun-Jung Jung et al.
ANNALS OF LABORATORY MEDICINE (2013)
Contribution of epigenetic alteration of BRCA1 and BRCA2 genes in breast carcinomas in Tunisian patients
R. Ben Gacem et al.
CANCER EPIDEMIOLOGY (2012)
BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls
Remy Bosviel et al.
CANCER EPIDEMIOLOGY (2012)
Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls
Susan R. Sturgeon et al.
EPIGENETICS (2012)
BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer
Olafur A. Stefansson et al.
EPIGENETICS (2012)
Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer
Tamara Hansmann et al.
HUMAN MOLECULAR GENETICS (2012)
BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation
Takashi Iwamoto et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer
Ee Ming Wong et al.
CANCER PREVENTION RESEARCH (2011)
No difference in the frequency of locus-specific methylation in the peripheral blood DNA of women diagnosed with breast cancer and age-matched controls
Tomasz K. Wojdacz et al.
FUTURE ONCOLOGY (2011)
Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women
Nisreen Al-Moghrabi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
